Loading…
Data as of .
| Company | Industry | Market cap | 1M | 6M | Revenue growth | Op. margin | Fwd P/E |
|---|---|---|---|---|---|---|---|
| Lilly (Eli) LLY | Pharmaceuticals: Major | $1.30T | +8% | +36% | +46% | 51% | 29.5× |
| Johnson & Johnson JNJ | Pharmaceuticals: Major | $656B | +5% | +20% | +8% | 26% | 24.2× |
| AbbVie ABBV | Pharmaceuticals: Major | $506B | -1% | +35% | +11% | 36% | 18.1× |
| Merck & MRK | Pharmaceuticals: Major | $340B | -7% | +23% | +5% | 18% | 16.4× |
| UnitedHealth UNH | Managed Health Care | $314B | -17% | -8% | +3% | 5% | 15.4× |
| Thermo Fisher Scientific TMO | Medical Specialties | $257B | +1% | +53% | +8% | 19% | 25.7× |
| Amgen AMGN | Biotechnology | $240B | +1% | +34% | +9% | 36% | 18.3× |
| Gilead Sciences GILD | Biotechnology | $210B | +8% | +30% | +7% | 38% | 19.9× |
| Abbott Laboratories ABT | Medical Specialties | $181B | +2% | +18% | +10% | 14% | 17.9× |
| Danaher DHR | Medical Specialties | $161B | +2% | +34% | +6% | 21% | 25.1× |
| Pfizer PFE | Pharmaceuticals: Major | $160B | -7% | +9% | +1% | 26% | 9.9× |
| Intuitive Surgical ISRG | Medical Specialties | $146B | -4% | -6% | +20% | 32% | 34.8× |
| Vertex Pharmaceuticals VRTX | Pharmaceuticals: Major | $136B | +4% | +25% | +11% | 35% | 28.5× |
| Medtronic MDT | Medical Specialties | $129B | +6% | +30% | +10% | 20% | 16.8× |
| McKesson MCK | Medical Distributors | $125B | +5% | +44% | +8% | 2% | 22.1× |
| Bristol Myers Squibb BMY | Pharmaceuticals: Major | $122B | -3% | +3% | +4% | 33% | 9.2× |
| Stryker SYK | Medical Specialties | $121B | +5% | -1% | +8% | 25% | 19.9× |
| CVS Health CVS | Drugstore Chains | $104B | -14% | -13% | +7% | 4% | 9.6× |
| HCA Healthcare HCA | Hospital/Nursing Management | $99.5B | +2% | +20% | +6% | 15% | 15.6× |
| Regeneron Pharmaceuticals REGN | Pharmaceuticals: Major | $97.8B | +17% | +46% | +19% | 30% | 11.8× |
| Elevance Health ELV | Managed Health Care | $86.6B | -9% | +2% | +4% | 4% | 13.9× |
| Moderna MRNA | Biotechnology | $79.6B | -19% | +309% | +13% | -116% | n/a |
| Cigna CI | Managed Health Care | $75.2B | -7% | +1% | +7% | 4% | 8.8× |
| Cencora COR | Medical Distributors | $66.5B | +1% | +32% | +5% | 1% | 17.7× |
| Cardinal Health CAH | Medical Distributors | $64.3B | +8% | +40% | +10% | 1% | 21.1× |
| Boston Scientific BSX | Medical Specialties | $63.3B | -4% | -23% | +9% | 21% | 14.1× |
| Edwards Lifesciences EW | Medical Specialties | $60.5B | +19% | +27% | +13% | 29% | 32.3× |
| argenx SE Sponsored ADR ARGX | Biotechnology | $59.1B | +8% | +17% | +71% | 29% | 29.0× |
| Becton Dickinson BDX | Medical Specialties | $58.9B | +12% | +48% | -7% | 16% | 16.3× |
| Idexx Laboratories IDXX | Medical Specialties | $55.0B | +25% | +26% | +12% | 32% | 42.9× |
| Medline MDLN | Medical Specialties | $51.5B | +10% | +8% | +12% | 6% | 25.6× |
| Agilent Technologies A | Medical Specialties | $50.0B | +2% | +56% | +9% | 24% | 27.0× |
| Teva Pharmaceutical Industries Limited Sponsored ADR TEVA | Pharmaceuticals: Generic | $49.3B | +3% | +23% | -4% | 19% | 15.0× |
| Humana HUM | Managed Health Care | $46.3B | -10% | +27% | +22% | 2% | 22.1× |
| Waters WAT | Medical Specialties | $45.8B | +5% | +37% | +81% | 10% | 29.1× |
| Veeva Systems VEEV | Packaged Software | $44.9B | -13% | +68% | +16% | 30% | 28.7× |
| Iqvia IQV | Biotechnology | $42.5B | -4% | +50% | +9% | 14% | 18.7× |
| Natera NTRA | Biotechnology | $42.0B | -29% | +41% | +37% | -9% | n/a |
| Royalty Pharma RPRX | Pharmaceuticals: Major | $39.4B | +10% | +29% | +11% | 66% | 11.5× |
| GE HealthCare GEHC | Medical Specialties | $37.8B | +19% | +30% | +7% | 14% | 15.6× |
| Biogen BIIB | Pharmaceuticals: Major | $37.2B | +3% | +34% | +2% | 17% | 17.1× |
| Zoetis ZTS | Pharmaceuticals: Major | $34.8B | +7% | +7% | +1% | 37% | 13.8× |
| Revolution Medicines RVMD | Pharmaceuticals: Other | $34.6B | -19% | +6% | n/a | -853% | n/a |
| Mettler Toledo MTD | Medical Specialties | $34.6B | +6% | +60% | +7% | 29% | 33.7× |
| ResMed RMD | Medical Specialties | $34.1B | -1% | +16% | +9% | 34% | 19.7× |
| Centene CNC | Managed Health Care | $33.4B | -5% | +16% | +10% | 1% | 12.8× |
| Illumina ILMN | Medical Specialties | $31.8B | -22% | +48% | +6% | 21% | 35.2× |
| Dexcom DXCM | Medical Specialties | $30.8B | -4% | +16% | +13% | 24% | 28.0× |
| Labcorp LH | Medical/Nursing Services | $30.1B | +15% | +44% | +6% | 11% | 19.3× |
| Quest Diagnostics DGX | Services to the Health Industry | $28.6B | +10% | +34% | +9% | 15% | 22.4× |
| West Pharmaceutical Services WST | Medical Specialties | $28.1B | +4% | +32% | +13% | 23% | 40.2× |
| Roivant Sciences ROIV | Pharmaceuticals: Major | $28.1B | +11% | +20% | +102% | -3,234% | n/a |
| Insmed INSM | Pharmaceuticals: Major | $26.3B | +25% | +3% | +240% | -42% | n/a |
| Steris STE | Medical Specialties | $25.2B | +15% | +21% | +8% | 20% | 21.9× |
| United Therapeutics UTHR | Biotechnology | $24.6B | +4% | +2% | +2% | 44% | 23.9× |
| Incyte INCY | Pharmaceuticals: Major | $24.0B | +1% | +21% | +25% | 12% | 15.1× |
| Viatris VTRS | Pharmaceuticals: Major | $23.3B | +9% | +23% | +5% | 11% | 7.5× |
| Tenet Healthcare THC | Hospital/Nursing Management | $21.6B | 0% | +45% | +6% | 17% | 13.4× |
| BioNTech SE Sponsored ADR BNTX | Biotechnology | $20.6B | -9% | -8% | -21% | -61% | n/a |
| Alnylam Pharmaceuticals ALNY | Pharmaceuticals: Major | $20.0B | -35% | -50% | +56% | 20% | 21.2× |
| Guardant Health GH | Medical Specialties | $19.6B | -11% | +26% | +42% | -39% | n/a |
| Zimmer Biomet ZBH | Medical Specialties | $19.6B | +8% | +21% | +7% | 16% | 11.7× |
| Medpace MEDP | Miscellaneous Commercial Services | $18.1B | +4% | +53% | +20% | 21% | 33.5× |
| Revvity RVTY | Medical Specialties | $17.0B | -2% | +61% | +5% | 16% | 26.2× |
| Ascendis Pharma A/S ASND | Pharmaceuticals: Major | $16.9B | +15% | +12% | +94% | 18% | 28.0× |
| Exelixis EXEL | Pharmaceuticals: Major | $16.7B | +6% | +37% | +9% | 40% | 17.7× |
| Neurocrine Biosciences NBIX | Biotechnology | $16.5B | +15% | +5% | +38% | 25% | 18.0× |
| Charles River Laboratories CRL | Miscellaneous Commercial Services | $16.0B | +6% | +114% | -1% | 15% | 26.2× |
| Jazz Pharmaceuticals Public JAZZ | Pharmaceuticals: Major | $15.9B | +16% | +4% | +13% | 25% | 9.3× |
| BridgeBio Pharma BBIO | Biotechnology | $15.2B | +15% | +14% | +167% | -37% | n/a |
| Solventum SOLV | Medical/Nursing Services | $14.7B | 0% | +14% | -3% | 8% | 11.7× |
| ICON ICLR | Miscellaneous Commercial Services | $14.6B | +12% | +70% | +1% | 10% | 17.3× |
| Glaukos GKOS | Medical Specialties | $13.8B | +34% | +62% | +47% | -9% | 161.5× |
| BrightSpring Health Services BTSG | Medical/Nursing Services | $13.6B | +9% | +17% | +23% | 4% | 28.8× |
| Baxter International BAX | Medical Specialties | $13.5B | +7% | +39% | +5% | 6% | 12.7× |
| Elanco Animal Health ELAN | Biotechnology | $13.3B | +18% | +28% | +12% | 8% | 21.5× |
| Encompass Health EHC | Medical/Nursing Services | $13.2B | +11% | +27% | +9% | 18% | 20.1× |
| Penumbra PEN | Medical Specialties | $12.6B | -1% | -2% | +17% | 12% | 55.7× |
| BioMarin Pharmaceutical BMRN | Biotechnology | $11.9B | +9% | +22% | +20% | 19% | 11.2× |
| Align Technology ALGN | Medical Specialties | $11.6B | +9% | 0% | +4% | 19% | 13.8× |
| Cooper Companies (The) COO | Medical Specialties | $11.6B | +3% | -2% | +5% | 19% | 13.4× |
| Bio-Techne TECH | Biotechnology | $11.4B | 0% | +56% | +1% | 21% | 34.4× |
| Repligen RGEN | Pharmaceuticals: Major | $11.0B | -3% | +55% | +14% | 9% | 71.0× |
| Halozyme Therapeutics HALO | Biotechnology | $10.9B | -23% | +39% | +45% | 57% | 9.5× |
| Molina Healthcare MOH | Managed Health Care | $10.8B | -6% | +13% | -1% | 1% | 24.7× |
| Universal Health Services UHS | Hospital/Nursing Management | $10.7B | 0% | +13% | +8% | 11% | 8.3× |
| Ensign ENSG | Medical/Nursing Services | $10.7B | +4% | +3% | +17% | 9% | 21.3× |
| Avantor AVTR | Medical Specialties | $10.4B | -8% | +95% | +1% | 8% | 17.5× |
| Kymera Therapeutics KYMR | Biotechnology | $10.3B | +7% | +50% | +134% | -396% | n/a |
| Qiagen QGEN | Medical Specialties | $10.2B | +1% | +41% | +2% | 25% | 19.5× |
| DaVita DVA | Medical/Nursing Services | $10.2B | -8% | -18% | +6% | 15% | 10.1× |
| Bio-Rad Laboratories BIO | Medical Specialties | $10.1B | +4% | +29% | +1% | 9% | 34.6× |
| TG Therapeutics TGTX | Pharmaceuticals: Major | $9.99B | +21% | +66% | +69% | 21% | 25.2× |
| Insulet PODD | Medical Specialties | $9.71B | -2% | -11% | +26% | 18% | 18.6× |
| Bruker BRKR | Medical Specialties | $9.66B | +13% | +43% | +2% | 10% | 27.0× |
| Spyre Therapeutics SYRE | Pharmaceuticals: Major | $9.64B | +11% | +41% | n/a | n/a | n/a |
| Henry Schein HSIC | Medical Distributors | $9.47B | +1% | +17% | +6% | 6% | 14.7× |
| Krystal Biotech KRYS | Biotechnology | $9.34B | -3% | +4% | +26% | 48% | 36.3× |
| Globus Medical GMED | Medical Specialties | $9.34B | -11% | -16% | +13% | 23% | 13.7× |
| Vaxcyte PCVX | Biotechnology | $9.26B | -12% | +24% | n/a | n/a | n/a |
| Madrigal Pharmaceuticals MDGL | Pharmaceuticals: Major | $9.25B | -15% | -22% | +93% | -11% | 81.5× |
| Praxis Precision Medicines PRAX | Pharmaceuticals: Major | $8.53B | +15% | -9% | -100% | n/a | n/a |
| Summit Therapeutics SMMT | Biotechnology | $8.40B | -35% | -41% | n/a | n/a | n/a |
| Protagonist Therapeutics PTGX | Pharmaceuticals: Major | $8.30B | -8% | +26% | +164% | 59% | 1,532.5× |
| Rhythm Pharmaceuticals RYTM | Pharmaceuticals: Major | $8.25B | +32% | +31% | +61% | -67% | n/a |
| Twist Bioscience TWST | Biotechnology | $7.93B | -18% | +117% | +22% | -29% | n/a |
| Alkermes Public ALKS | Pharmaceuticals: Major | $7.87B | +6% | +27% | +15% | 5% | n/a |
| Amneal Pharmaceuticals AMRX | Pharmaceuticals: Major | $7.62B | +10% | +79% | +9% | 16% | 19.2× |
| Oscar Health OSCR | Managed Health Care | $7.54B | -18% | +18% | +55% | 5% | 10.6× |
| 10x Genomics TXG | Biotechnology | $7.51B | -20% | +138% | -4% | -11% | n/a |
| Kiniksa Pharmaceuticals International KNSA | Pharmaceuticals: Major | $7.47B | +14% | +75% | +58% | 14% | 56.6× |
| Corcept Therapeutics CORT | Pharmaceuticals: Major | $7.42B | -42% | +15% | +30% | 12% | 15.3× |
| PACS PACS | Hospital/Nursing Management | $7.35B | -3% | +25% | +11% | 8% | 17.5× |
| Cytokinetics CYTK | Pharmaceuticals: Major | $7.15B | -20% | -35% | +30% | -625% | n/a |
| CG Oncology CGON | Biotechnology | $7.15B | +29% | +24% | +184% | -4,294% | n/a |
| ImmunityBio IBRX | Pharmaceuticals: Major | $7.13B | -24% | -17% | +121% | -150% | n/a |
| Chemed CHE | Hospital/Nursing Management | $7.12B | +6% | +24% | +5% | 14% | 20.2× |
| Axsome Therapeutics AXSM | Biotechnology | $7.05B | -16% | -42% | +54% | -19% | 77.1× |
| Immunovant IMVT | Biotechnology | $6.86B | +16% | -7% | n/a | n/a | n/a |
| Lantheus LNTH | Medical Specialties | $6.67B | +2% | +6% | +2% | 19% | 15.5× |
| Teleflex TFX | Medical Specialties | $6.58B | +26% | +23% | -29% | 12% | 16.7× |
| Oruka Therapeutics ORKA | Pharmaceuticals: Major | $6.49B | +21% | +58% | n/a | n/a | n/a |
| Belite Bio, Inc. ADR BLTE | Pharmaceuticals: Major | $6.41B | +1% | +9% | n/a | n/a | n/a |
| Kodiak Sciences KOD | Biotechnology | $6.40B | +5% | +170% | n/a | n/a | n/a |
| Arrowhead Pharmaceuticals ARWR | Biotechnology | $6.09B | -27% | -44% | -46% | -157% | n/a |
| Mirum Pharmaceuticals MIRM | Pharmaceuticals: Major | $6.04B | +9% | -5% | +42% | -21% | n/a |
| Supernus Pharmaceuticals SUPN | Pharmaceuticals: Major | $6.02B | -30% | -41% | +16% | 45% | 8.0× |
| Ligand Pharmaceuticals LGND | Pharmaceuticals: Major | $5.98B | -3% | +37% | +1% | 14% | 27.3× |
| Scholar Rock SRRK | Biotechnology | $5.86B | +16% | -1% | n/a | -71,732% | n/a |
| RadNet RDNT | Medical/Nursing Services | $5.66B | +3% | +32% | +21% | 5% | 93.2× |
| Haemonetics HAE | Medical Specialties | $5.59B | +4% | +106% | +4% | 19% | 20.7× |
| Caris Life Sciences CAI | Biotechnology | $5.59B | -37% | +24% | +61% | 13% | 79.4× |
| Concentra Group Holdings Parent CON | Medical/Nursing Services | $5.31B | +8% | +65% | +12% | 17% | 22.3× |
| Veradermics MANE | Pharmaceuticals: Major | $5.27B | -2% | +19% | n/a | n/a | n/a |
| Lifestance Health LFST | Medical/Nursing Services | $5.24B | +13% | +79% | +23% | 6% | 51.8× |
| LivaNova LIVN | Medical Specialties | $5.21B | +19% | +28% | +12% | 15% | 20.9× |
| Merit Medical Systems MMSI | Medical Specialties | $5.15B | -6% | +33% | +9% | 14% | 19.1× |
| Liquidia LQDA | Pharmaceuticals: Major | $5.08B | +55% | -9% | +798% | 47% | 13.8× |
| PTC Therapeutics PTCT | Pharmaceuticals: Major | $5.03B | -4% | -15% | -35% | 22% | 31.2× |
| Cogent Biosciences COGT | Biotechnology | $4.84B | -11% | -16% | n/a | n/a | n/a |
| Erasca ERAS | Pharmaceuticals: Major | $4.83B | -6% | +24% | n/a | n/a | n/a |
| Travere Therapeutics TVTX | Pharmaceuticals: Major | $4.82B | -4% | +16% | +49% | -3% | 17.1× |
| MiniMed MMED | Medical Specialties | $4.78B | -3% | +46% | +14% | 14% | 26.3× |
| Option Care Health OPCH | Medical/Nursing Services | $4.75B | +1% | +43% | +4% | 6% | 15.7× |
| Dianthus Therapeutics DNTH | Biotechnology | $4.73B | +7% | -5% | -12% | -8,684% | n/a |
| Sotera Health SHC | Medical Specialties | $4.65B | -9% | +5% | +7% | 37% | 15.7× |
| Adaptive Biotechnologies ADPT | Biotechnology | $4.61B | +17% | +104% | +18% | -16% | n/a |
| GRAIL GRAL | Medical Specialties | $4.59B | -18% | +67% | +17% | -332% | n/a |
| Ionis Pharmaceuticals IONS | Pharmaceuticals: Major | $4.56B | -40% | -64% | -1% | -59% | n/a |
| Edgewise Therapeutics EWTX | Biotechnology | $4.53B | +4% | +26% | n/a | n/a | n/a |
| ICU Medical ICUI | Medical Specialties | $4.46B | +11% | +38% | -6% | 8% | 19.4× |
| BillionToOne BLLN | Medical/Nursing Services | $4.37B | -12% | +7% | +72% | 10% | 115.3× |
| Stevanato STVN | Medical Specialties | $4.19B | -19% | -13% | +12% | 18% | 22.5× |
| Hims & Hers Health HIMS | Medical/Nursing Services | $4.00B | -42% | -26% | +30% | -1% | n/a |
| Definium Therapeutics DFTX | Pharmaceuticals: Major | $3.99B | -17% | +40% | n/a | n/a | n/a |
| CareDx CDNA | Medical Specialties | $3.91B | +8% | +252% | +39% | 1% | 50.6× |
| CRISPR Therapeutics CRSP | Biotechnology | $3.90B | -19% | -17% | -34% | -2,059% | n/a |
| Envista NVST | Medical Specialties | $3.81B | +3% | 0% | +10% | 12% | 14.7× |
| Tarsus Pharmaceuticals TARS | Pharmaceuticals: Major | $3.74B | +7% | +17% | +86% | -10% | n/a |
| Xenon Pharmaceuticals XENE | Pharmaceuticals: Major | $3.71B | +4% | -31% | -100% | n/a | n/a |
| Tango Therapeutics TNGX | Biotechnology | $3.71B | -13% | +4% | -100% | n/a | n/a |
| SELLAS Life Sciences SLS | Pharmaceuticals: Major | $3.66B | +50% | +100% | n/a | n/a | n/a |
| Organon & OGN | Pharmaceuticals: Major | $3.66B | +1% | +3% | -3% | 20% | 4.0× |
| Relay Therapeutics RLAY | Biotechnology | $3.65B | -11% | +27% | +24% | -3,095% | n/a |
| AbCellera Biologics ABCL | Biotechnology | $3.60B | -6% | +141% | +92% | -298% | n/a |
| Disc Medicine IRON | Biotechnology | $3.55B | -2% | +16% | n/a | n/a | n/a |
| Surgery Partners SGRY | Hospital/Nursing Management | $3.53B | +74% | +100% | +2% | 13% | 77.2× |
| Parabilis Medicines PBLS | Pharmaceuticals: Major | $3.52B | +5% | n/a | n/a | n/a | n/a |
| Acadia Healthcare ACHC | Medical/Nursing Services | $3.49B | +20% | +56% | +4% | 10% | 18.6× |
| Arcutis Biotherapeutics ARQT | Pharmaceuticals: Major | $3.49B | -16% | +35% | +60% | 7% | 41.0× |
| Iovance Biotherapeutics IOVA | Biotechnology | $3.46B | -50% | +111% | +51% | -61% | n/a |
| Amylyx Pharmaceuticals AMLX | Pharmaceuticals: Major | $3.42B | -7% | +93% | +100% | n/a | n/a |
| Viridian Therapeutics VRDN | Pharmaceuticals: Major | $3.42B | +34% | +71% | -63% | -1,781% | n/a |
| Axogen AXGN | Medical Specialties | $3.40B | +57% | +33% | +24% | -5% | 87.3× |
| Pulse Biosciences PLSE | Medical Specialties | $3.37B | -10% | +76% | +1,637% | -5,821% | n/a |
| TransMedics TMDX | Medical Specialties | $3.35B | +29% | +42% | +28% | 12% | 43.4× |
| Viking Therapeutics VKTX | Pharmaceuticals: Major | $3.34B | -2% | -9% | n/a | n/a | n/a |
| Enliven Therapeutics ELVN | Biotechnology | $3.30B | +9% | +7% | n/a | n/a | n/a |
| iRhythm IRTC | Medical Specialties | $3.19B | -17% | -19% | +22% | 5% | 99.8× |
| National HealthCare NHC | Hospital/Nursing Management | $3.16B | -19% | +1% | +6% | 0% | n/a |
| Legend Biotech Corp. Sponsored ADR LEGN | Pharmaceuticals: Major | $3.12B | -15% | -42% | +50% | 3% | 34.2× |
| Xeris Biopharma XERS | Biotechnology | $3.10B | +53% | +173% | +38% | 13% | 49.7× |
| ACADIA Pharmaceuticals ACAD | Pharmaceuticals: Major | $3.08B | -13% | -15% | +15% | 10% | 17.8× |
| ADMA Biologics ADMA | Biotechnology | $3.01B | +21% | +58% | +6% | 45% | 16.7× |
| Vericel VCEL | Pharmaceuticals: Major | $2.99B | +45% | +66% | +25% | 8% | 68.3× |
| Dyne Therapeutics DYN | Biotechnology | $2.97B | -2% | -10% | n/a | n/a | n/a |
| Denali Therapeutics DNLI | Biotechnology | $2.95B | -3% | -2% | n/a | -2,488% | n/a |
| AtriCure ATRC | Medical Specialties | $2.82B | -4% | +91% | +14% | 3% | 212.4× |
| Celcuity CELC | Medical Specialties | $2.73B | -7% | -60% | n/a | n/a | n/a |
| Progyny PGNY | Miscellaneous Commercial Services | $2.66B | +27% | +41% | +6% | 9% | 23.2× |
| MBX Biosciences MBX | Biotechnology | $2.65B | 0% | +70% | n/a | n/a | n/a |
| Xencor XNCR | Biotechnology | $2.58B | +38% | +204% | +34% | -73% | n/a |
| IDEAYA Biosciences IDYA | Pharmaceuticals: Major | $2.56B | -25% | -11% | -83% | -1,267% | n/a |
| Neogen NEOG | Medical Specialties | $2.42B | -5% | +25% | 0% | 0% | 32.6× |
| Pediatrix Medical MD | Medical/Nursing Services | $2.41B | +10% | +37% | +2% | 12% | 12.4× |
| Prestige Consumer Healthcare PBH | Pharmaceuticals: Major | $2.40B | +3% | +7% | +5% | 25% | 10.6× |
| Aveanna Healthcare AVAH | Medical/Nursing Services | $2.37B | -15% | +41% | +17% | 12% | 12.2× |
| NewAmsterdam Pharma NAMS | Pharmaceuticals: Major | $2.37B | -8% | -45% | -26% | -900% | n/a |
| Perrigo PRGO | Pharmaceuticals: Major | $2.35B | +5% | +52% | -4% | 5% | 6.7× |
| Regencell Bioscience RGC | Pharmaceuticals: Major | $2.33B | -55% | -83% | n/a | n/a | n/a |
| Arcus Biosciences RCUS | Biotechnology | $2.27B | -34% | -34% | -58% | -475% | n/a |
| Addus HomeCare ADUS | Medical/Nursing Services | $2.25B | +2% | +29% | +12% | 11% | 16.2× |
| Pharvaris PHVS | Biotechnology | $2.21B | +2% | +7% | n/a | n/a | n/a |
| Beam Therapeutics BEAM | Biotechnology | $2.17B | -16% | -22% | +163% | -268% | n/a |
| Celldex Therapeutics CLDX | Biotechnology | $2.16B | -9% | -11% | -94% | -211,685% | n/a |
| Palvella Therapeutics PVLA | Biotechnology | $2.14B | +18% | +27% | -100% | n/a | n/a |
| Alamar Biosciences ALMR | Biotechnology | $2.12B | +8% | +51% | +195% | -42% | n/a |
| Establishment Labs ESTA | Medical Specialties | $2.11B | +16% | +1% | +38% | -7% | n/a |
| Veracyte VCYT | Medical Specialties | $2.06B | -43% | -43% | +18% | 16% | 17.1× |
| Brookdale Senior Living BKD | Hospital/Nursing Management | $2.06B | -15% | -36% | -8% | 6% | 482.6× |
| Azenta AZTA | Medical/Nursing Services | $2.03B | +36% | +162% | +5% | -2% | 83.2× |
| Ardent Health ARDT | Hospital/Nursing Management | $2.03B | +19% | +52% | +2% | 5% | 11.9× |
| Aurinia Pharmaceuticals AUPH | Biotechnology | $2.03B | -10% | -5% | +21% | 45% | 18.1× |
| Immunome IMNM | Biotechnology | $1.98B | -6% | -22% | -100% | n/a | n/a |
| NeoGenomics NEO | Medical/Nursing Services | $1.98B | -8% | +72% | +11% | -6% | 53.5× |
| Fortrea FTRE | Miscellaneous Commercial Services | $1.98B | -10% | +50% | -3% | 2% | 21.6× |
| Biohaven BHVN | Pharmaceuticals: Major | $1.95B | +9% | +46% | n/a | n/a | n/a |
| Harmony Biosciences HRMY | Pharmaceuticals: Major | $1.94B | -14% | +6% | +20% | 22% | 8.6× |
| Trevi Therapeutics TRVI | Biotechnology | $1.93B | +5% | -3% | n/a | n/a | n/a |
| Maravai Lifesciences MRVI | Biotechnology | $1.92B | +2% | +101% | +11% | -17% | n/a |
| BioCryst Pharmaceuticals BCRX | Biotechnology | $1.88B | -8% | -16% | +60% | 42% | 11.1× |
| Replimune REPL | Biotechnology | $1.88B | +73% | +321% | n/a | n/a | n/a |
| Septerna SEPN | Biotechnology | $1.88B | 0% | +41% | +337% | -76% | n/a |
| First Tracks Biotherapeutics TRAX | Biotechnology | $1.87B | +8% | +175% | n/a | n/a | n/a |
| Vera Therapeutics VERA | Biotechnology | $1.85B | -15% | -26% | n/a | -4,160% | n/a |
| Hemab Therapeutics COAG | Biotechnology | $1.83B | +15% | +48% | n/a | n/a | n/a |
| Zymeworks ZYME | Pharmaceuticals: Major | $1.81B | -3% | +5% | +98% | 17% | 160.4× |
| Lycia Therapeutics LYCA | Biotechnology | $1.81B | n/a | n/a | -55% | -593% | n/a |
| Ultragenyx Pharmaceutical RARE | Pharmaceuticals: Major | $1.81B | +11% | -24% | +16% | -64% | 9.6× |
| Zenas BioPharma ZBIO | Biotechnology | $1.79B | -6% | +35% | -27% | -2,748% | n/a |
| Eton Pharmaceuticals ETON | Pharmaceuticals: Major | $1.79B | +24% | +226% | +101% | 29% | 24.6× |
| Agios Pharmaceuticals AGIO | Pharmaceuticals: Major | $1.78B | -19% | +4% | +214% | -298% | n/a |
| Recursion Pharmaceuticals RXRX | Biotechnology | $1.76B | -23% | -5% | +56% | -725% | n/a |
| Stoke Therapeutics STOK | Biotechnology | $1.75B | 0% | -12% | -86% | -913% | n/a |
| LeMaitre Vascular LMAT | Medical Specialties | $1.73B | -9% | -25% | +12% | 28% | 24.5× |
| Maze Therapeutics MAZE | Pharmaceuticals: Major | $1.71B | -4% | +27% | -100% | -821% | n/a |
| DENTSPLY SIRONA XRAY | Medical Specialties | $1.69B | -4% | -13% | -1% | 5% | 6.8× |
| Kestra Medical Technologies KMTS | Medical Specialties | $1.69B | 0% | +36% | +61% | -134% | n/a |
| Inspire Medical Systems INSP | Medical Specialties | $1.68B | -19% | +32% | 0% | 2% | 41.3× |
| Braveheart Bio BRVE | Pharmaceuticals: Major | $1.67B | -9% | n/a | n/a | n/a | n/a |
| Butterfly Network BFLY | Medical Specialties | $1.63B | -17% | +38% | +39% | -36% | n/a |
| ANI Pharmaceuticals ANIP | Biotechnology | $1.62B | -2% | -13% | +26% | 15% | 7.5× |
| Personalis PSNL | Medical/Nursing Services | $1.62B | -6% | +88% | +17% | -157% | n/a |
| Alvotech ALVO | Biotechnology | $1.62B | -11% | +38% | -14% | 12% | 22.6× |
| Sonida Senior Living SNDA | Medical/Nursing Services | $1.59B | -6% | -11% | +70% | -8% | n/a |
| BellRing Brands BRBR | Beverages: Non-Alcoholic | $1.59B | +44% | +52% | +4% | 11% | 10.6× |
| Vir Biotechnology VIR | Biotechnology | $1.57B | -15% | +3% | +1,696% | -70% | n/a |
| Enovis ENOV | Medical Specialties | $1.56B | +31% | +2% | +3% | 4% | 7.6× |
| Sarepta Therapeutics SRPT | Pharmaceuticals: Major | $1.56B | -24% | -15% | -19% | 0% | n/a |
| GeneDx WGS | Medical/Nursing Services | $1.56B | -24% | +16% | +15% | -14% | 54.2× |
| Nurix Therapeutics NRIX | Biotechnology | $1.54B | -46% | -14% | +739% | 41% | n/a |
| Precigen PGEN | Biotechnology | $1.53B | -37% | 0% | +2,388% | 21% | 7.3× |
| Kailera Therapeutics KLRA | Biotechnology | $1.53B | -9% | -41% | n/a | n/a | n/a |
| agilon health AGL | Medical/Nursing Services | $1.52B | -1% | +12% | +2% | -2% | 34.1× |
| Korsana Biosciences KRSA | Biotechnology | $1.52B | +7% | +54% | -64% | -5,277% | n/a |
| Astrana Health ASTH | Services to the Health Industry | $1.47B | -23% | -24% | +35% | 3% | 17.6× |
| Teladoc Health TDOC | Medical/Nursing Services | $1.47B | +30% | +24% | -2% | -5% | n/a |
| UroGen Pharma URGN | Biotechnology | $1.46B | -15% | -1% | +159% | -12% | 16.7× |
| AMN Healthcare Services AMN | Personnel Services | $1.45B | -10% | +40% | +29% | 6% | 40.8× |
| PROCEPT BioRobotics PRCT | Medical Specialties | $1.45B | +34% | -10% | +17% | -34% | n/a |
| Phibro Animal Health PAHC | Pharmaceuticals: Major | $1.44B | -8% | +5% | +10% | 13% | 9.9× |
| Immunocore Holdings Plc Shs Sponsored American Depositary Shares Repr 1 Sh IMCR | Biotechnology | $1.44B | -16% | -7% | +13% | -7% | n/a |
| CONMED CNMD | Medical Specialties | $1.43B | +1% | +30% | +2% | 2% | 10.4× |
| U.S. Physical Therapy USPH | Medical/Nursing Services | $1.42B | +10% | +53% | +10% | 10% | 29.4× |
| uniQure QURE | Biotechnology | $1.42B | -11% | -17% | +28% | -1,027% | n/a |
| Damora Therapeutics DMRA | Pharmaceuticals: Major | $1.42B | +11% | -5% | n/a | n/a | n/a |
| Absci ABSI | Biotechnology | $1.41B | -10% | +65% | -47% | -9,155% | n/a |
| Alignment Healthcare ALHC | Managed Health Care | $1.41B | -21% | -60% | +36% | 1% | n/a |
| AnaptysBio ANAB | Biotechnology | $1.40B | +4% | -22% | +13% | 62% | 4.9× |
| Rapport Therapeutics RAPP | Biotechnology | $1.39B | -20% | -34% | n/a | -838% | n/a |
| Intellia Therapeutics NTLA | Biotechnology | $1.37B | -17% | -20% | -8% | -821% | n/a |
| Tyra Bioscience TYRA | Biotechnology | $1.35B | -4% | -41% | n/a | n/a | n/a |
| Lumexa Imaging LMRI | Medical/Nursing Services | $1.35B | +31% | +89% | +8% | 2% | 16.0× |
| Generate Biomedicines GENB | Biotechnology | $1.34B | -20% | -20% | +56% | -737% | n/a |
| Nuvation Bio NUVB | Biotechnology | $1.34B | -21% | -16% | +654% | -61% | n/a |
| Windward Bio WWB | Pharmaceuticals: Major | $1.31B | n/a | n/a | n/a | n/a | n/a |
| Novavax NVAX | Biotechnology | $1.31B | -30% | -14% | -61% | -17% | 134.6× |
| MannKind MNKD | Pharmaceuticals: Major | $1.31B | +31% | +25% | +32% | -2% | 174.4× |
| Innoviva INVA | Pharmaceuticals: Major | $1.31B | -14% | -17% | +12% | 38% | 9.5× |
| Ocular Therapeutix OCUL | Pharmaceuticals: Major | $1.31B | -11% | -26% | -10% | -681% | n/a |
| Taysha Gene Therapies TSHA | Biotechnology | $1.30B | -3% | -27% | -13% | -2,998% | n/a |
| LB Pharmaceuticals LBRX | Pharmaceuticals: Major | $1.30B | -2% | +43% | n/a | n/a | n/a |
| STAAR Surgical STAA | Medical Specialties | $1.27B | +14% | -23% | +42% | 7% | 46.9× |
| Amphastar Pharmaceuticals AMPH | Pharmaceuticals: Major | $1.27B | +15% | +64% | +3% | 19% | 9.1× |
| Pennant PNTG | Medical/Nursing Services | $1.26B | -14% | +1% | +39% | 6% | 23.7× |
| OPKO Health OPK | Medical/Nursing Services | $1.25B | +2% | +37% | -22% | -29% | n/a |
| NovoCure NVCR | Medical Specialties | $1.25B | -32% | -40% | +13% | -17% | n/a |
| GH Research GHRS | Pharmaceuticals: Major | $1.25B | -5% | -19% | n/a | n/a | n/a |
| Structure Therapeutics, Inc. Sponsored ADR GPCR | Pharmaceuticals: Major | $1.24B | -24% | -53% | n/a | n/a | n/a |
| Avalyn Pharma AVLN | Pharmaceuticals: Major | $1.23B | +12% | -1% | n/a | n/a | n/a |
| Silence Therapeutics PLC Sponsored ADR SLN | Miscellaneous Commercial Services | $1.23B | +1% | +244% | -98% | -11,920% | n/a |
| Mineralys Therapeutics MLYS | Biotechnology | $1.22B | -36% | -52% | n/a | n/a | n/a |
| Harrow HROW | Pharmaceuticals: Major | $1.21B | +15% | +4% | +21% | 1% | 26.8× |
| Tandem Diabetes Care TNDM | Medical Specialties | $1.19B | +3% | +13% | +7% | -2% | n/a |
| Nutex Health NUTX | Medical/Nursing Services | $1.19B | -13% | +42% | -19% | 39% | 6.5× |
| Nektar Therapeutics NKTR | Pharmaceuticals: Major | $1.18B | -12% | -50% | -17% | -304% | n/a |
| Kardigan KARD | Biotechnology | $1.15B | -9% | n/a | n/a | n/a | n/a |
| COMPASS Pathways Plc Sponsored ADR CMPS | Biotechnology | $1.15B | -32% | -25% | n/a | n/a | n/a |
| GoodRx GDRX | Medical/Nursing Services | $1.15B | -5% | +33% | -2% | 12% | 10.6× |
| Alpha Tau Medical DRTS | Medical Specialties | $1.11B | -8% | +7% | n/a | n/a | n/a |
| Vor Biopharma VOR | Biotechnology | $1.10B | -6% | +15% | n/a | n/a | n/a |
| Alphatec ATEC | Medical Specialties | $1.10B | -35% | -14% | +15% | -3% | 15.1× |
| Freenome FRNM | Medical Specialties | $1.08B | -31% | n/a | n/a | 36% | n/a |
| Omeros OMER | Pharmaceuticals: Major | $1.08B | -12% | +24% | n/a | -56% | 4.3× |
| Integra LifeSciences IART | Medical Specialties | $1.08B | +4% | -10% | +1% | 12% | 6.0× |
| Jade Biosciences JBIO | Biotechnology | $1.07B | +4% | -34% | n/a | n/a | n/a |
| SI-BONE SIBN | Medical Specialties | $1.06B | +15% | +59% | +14% | -8% | n/a |
| IRadimed IRMD | Medical Specialties | $1.05B | -7% | -9% | +11% | 32% | 34.3× |
| Savara SVRA | Pharmaceuticals: Major | $1.04B | -1% | -7% | n/a | n/a | n/a |
| Alto Neuroscience ANRO | Biotechnology | $1.04B | +6% | +25% | n/a | n/a | n/a |
| Castle Biosciences CSTL | Medical Specialties | $1.03B | +1% | +67% | +10% | -7% | n/a |
| CryoPort CYRX | Air Freight/Couriers | $1.02B | +16% | +43% | +1% | -20% | n/a |
| Inhibrx Biosciences INBX | Biotechnology | $1.02B | -28% | -37% | +43% | -6,287% | n/a |
| AdaptHealth AHCO | Medical/Nursing Services | $1.01B | +21% | -30% | -3% | 3% | n/a |
| Ceribell CBLL | Medical Specialties | $995M | -7% | +42% | +31% | -70% | n/a |
| SpyGlass Pharma SGP | Biotechnology | $993M | +13% | +36% | n/a | n/a | n/a |
| Seaport Therapeutics SPTX | Pharmaceuticals: Major | $980M | -5% | +16% | n/a | n/a | n/a |
| MoonLake Immunotherapeutics MLTX | Pharmaceuticals: Major | $918M | +5% | -37% | n/a | n/a | n/a |
| Immatics IMTX | Pharmaceuticals: Major | $913M | -19% | -46% | -44% | -589% | n/a |
| Odyssey Therapeutics ODTX | Biotechnology | $912M | 0% | +12% | -33% | -5,415% | n/a |
| Artivion AORT | Medical Specialties | $905M | -20% | -18% | +14% | 5% | 383.6× |
| Aktis Oncology AKTS | Pharmaceuticals: Major | $895M | 0% | -15% | +337% | -837% | n/a |
| Bioventus BVS | Medical Specialties | $895M | -24% | -3% | +4% | 10% | 13.0× |
| Latigo Biotherapeutics LTGO | Pharmaceuticals: Major | $882M | -13% | n/a | n/a | n/a | n/a |
| Verastem VSTM | Biotechnology | $866M | -26% | +66% | +650% | -194% | n/a |
| City Therapeutics CTY | Pharmaceuticals: Major | $861M | -20% | n/a | +388% | -442% | n/a |
| Corvus Pharmaceuticals CRVS | Pharmaceuticals: Major | $860M | 0% | -16% | n/a | n/a | n/a |
| OrthoPediatrics KIDS | Medical Specialties | $826M | +35% | +71% | +16% | -8% | n/a |
| MeiraGTx MGTX | Biotechnology | $813M | -17% | -13% | +1,366% | 44% | n/a |
| Collegium Pharmaceutical COLL | Pharmaceuticals: Major | $806M | +12% | -24% | +8% | 15% | 3.7× |
| Rigel Pharmaceuticals RIGL | Pharmaceuticals: Major | $801M | -12% | +48% | +2% | 26% | 10.8× |
| Oric Pharmaceuticals ORIC | Pharmaceuticals: Major | $795M | -44% | -9% | n/a | n/a | n/a |
| Ironwood Pharmaceuticals IRWD | Pharmaceuticals: Major | $791M | +32% | +22% | +18% | 63% | 3.5× |
| Bambusa Therapeutics BBTX | Pharmaceuticals: Major | $791M | n/a | n/a | n/a | n/a | n/a |
| Ardelyx ARDX | Pharmaceuticals: Major | $784M | -3% | -50% | +18% | -8% | 252.9× |
| Beta Bionics BBNX | Medical Specialties | $779M | -19% | +42% | +44% | -73% | n/a |
| Monte Rosa Therapeutics GLUE | Biotechnology | $775M | -20% | -51% | -61% | -214% | n/a |
| Mesa Laboratories MLAB | Medical Specialties | $775M | +10% | +33% | +2% | 10% | 11.5× |
| Cytek Biosciences CTKB | Medical Specialties | $774M | +11% | +57% | +6% | -21% | n/a |
| Varex Imaging VREX | Medical Specialties | $771M | -1% | +79% | +5% | 8% | 19.9× |
| Syndax Pharmaceuticals SNDX | Biotechnology | $771M | -35% | -57% | +160% | -62% | n/a |
| Lexicon Pharmaceuticals LXRX | Pharmaceuticals: Major | $766M | +9% | -22% | -46% | -147% | n/a |
| Aura Biosciences AURA | Biotechnology | $743M | +9% | -4% | n/a | n/a | n/a |
| InMode INMD | Medical Specialties | $741M | -9% | -8% | +2% | 18% | 9.8× |
| OmniAb OABI | Miscellaneous Commercial Services | $741M | +2% | +97% | +91% | -116% | n/a |
| Apnimed APMD | Biotechnology | $726M | -6% | n/a | +380% | -140% | n/a |
| Sagimet Biosciences SGMT | Pharmaceuticals: Major | $722M | +4% | +52% | n/a | n/a | n/a |
| GMR Solutions GMRS | Medical/Nursing Services | $714M | +2% | -8% | -4% | 14% | 5.9× |
| Attovia Therapeutics ATTO | Biotechnology | $710M | +11% | +1,325% | n/a | -5,945% | n/a |
| Solid Biosciences SLDB | Biotechnology | $709M | -1% | -2% | n/a | n/a | n/a |
| Fulgent Genetics FLGT | Medical/Nursing Services | $702M | +24% | +53% | +5% | -38% | n/a |
| Nuvectis Pharma NVCT | Pharmaceuticals: Major | $698M | -1% | +91% | n/a | n/a | n/a |
| Prime Medicine PRME | Biotechnology | $695M | -3% | +35% | +18% | -2,584% | n/a |
| Delcath Systems DCTH | Medical Specialties | $685M | +33% | +75% | +38% | 5% | 358.9× |
| Kura Oncology KURA | Biotechnology | $674M | -26% | -29% | -24% | -394% | n/a |
| Annexon ANNX | Pharmaceuticals: Major | $671M | -8% | -30% | n/a | n/a | n/a |
| QuidelOrtho QDEL | Medical Specialties | $657M | -33% | -20% | -5% | -2% | 10.7× |
| SBC Medical SBC | Miscellaneous Commercial Services | $645M | +15% | +94% | +7% | 40% | 11.7× |
| Geron GERN | Biotechnology | $638M | -20% | -21% | +19% | -8% | 17.4× |
| Janux Therapeutics JANX | Biotechnology | $631M | -40% | -28% | +133% | -599% | n/a |
| Arbutus Biopharma ABUS | Pharmaceuticals: Major | $630M | -5% | -6% | +1,143% | 80% | n/a |
| Bicara Therapeutics BCAX | Pharmaceuticals: Major | $623M | -49% | -54% | n/a | n/a | n/a |
| Olema Pharmaceuticals OLMA | Pharmaceuticals: Major | $619M | -3% | -49% | n/a | n/a | n/a |
| Adlai Nortye Ltd. Sponsored ADR ANL | Miscellaneous Commercial Services | $610M | -18% | -23% | n/a | -134% | n/a |
| Achieve Life Sciences QUIT | Pharmaceuticals: Major | $609M | n/a | n/a | n/a | n/a | n/a |
| Design Therapeutics DSGN | Biotechnology | $606M | -15% | -15% | n/a | n/a | n/a |
| Surrozen SRZN | Biotechnology | $605M | +26% | +17% | +192% | -485% | n/a |
| Sight Sciences SGHT | Medical Specialties | $599M | +25% | +122% | +16% | -30% | n/a |
| Immix Biopharma IMMX | Pharmaceuticals: Major | $596M | -20% | -20% | n/a | n/a | n/a |
| vVARDIS VVVV | Medical Specialties | $594M | n/a | n/a | +148% | -72% | n/a |
| Tactile Systems Technology TCMD | Medical Specialties | $592M | +12% | +6% | +14% | 9% | 21.1× |
| Orchestra BioMed OBIO | Medical Specialties | $587M | +28% | +87% | +1,007% | -195% | n/a |
| Cullinan Therapeutics CGEM | Pharmaceuticals: Major | $585M | -39% | -37% | n/a | n/a | n/a |
| 4D Molecular Therapeutics FDMT | Biotechnology | $578M | -20% | +23% | +79,952% | -226% | n/a |
| Pacific Biosciences of California PACB | Medical Specialties | $573M | -7% | +54% | +4% | -98% | n/a |
| Alumis ALMS | Pharmaceuticals: Major | $569M | -34% | -80% | -67% | -5,375% | n/a |
| Entera Bio ENTX | Pharmaceuticals: Major | $568M | +8% | +163% | -100% | n/a | n/a |
| ArriVent BioPharma AVBP | Pharmaceuticals: Other | $564M | -42% | -60% | n/a | -3,620% | n/a |
| NRC Health NRC | Services to the Health Industry | $555M | +26% | +36% | +3% | 11% | 26.4× |
| Aclaris Therapeutics ACRS | Pharmaceuticals: Major | $555M | -7% | -23% | -59% | -1,412% | n/a |
| Sana Biotechnology SANA | Biotechnology | $554M | -22% | -41% | n/a | n/a | n/a |
| Zevra Therapeutics ZVRA | Pharmaceuticals: Major | $552M | -11% | -9% | +75% | 31% | 11.3× |
| Ginkgo Bioworks DNA | Medical/Nursing Services | $547M | -14% | +9% | -44% | -242% | n/a |
| Wave Life Sciences WVE | Biotechnology | $546M | -19% | -55% | -35% | -321% | n/a |
| Climb Bio CLYM | Biotechnology | $546M | -14% | -12% | n/a | n/a | n/a |
| Jin Medical International ZJYL | Medical Specialties | $532M | +66% | +47% | -14% | 2% | n/a |
| Myriad Genetics MYGN | Medical Specialties | $530M | 0% | +45% | -3% | -13% | n/a |
| Electra Therapeutics ETRA | Pharmaceuticals: Major | $530M | -4% | n/a | n/a | n/a | n/a |
| AVITA Medical RCEL | Medical Specialties | $529M | +22% | +290% | +17% | -34% | n/a |
| Anbio Biotechnology NNNN | Medical Specialties | $518M | -3% | -89% | +10% | 67% | n/a |
| Anteris Technologies Global AVR | Medical Specialties | $508M | -17% | -40% | +9% | -4,880% | n/a |
| Indaptus Therapeutics INDP | Pharmaceuticals: Major | $505M | +11% | +147% | n/a | n/a | n/a |
| Gyre Therapeutics GYRE | Pharmaceuticals: Major | $500M | -30% | -28% | +14% | -18% | n/a |
| Alpha Teknova TKNO | Pharmaceuticals: Major | $496M | +7% | +113% | +15% | -32% | n/a |
| Crescent Biopharma CBIO | Biotechnology | $482M | -5% | -34% | n/a | -1,217% | n/a |
| REGENXBIO RGNX | Pharmaceuticals: Major | $480M | -2% | +22% | -5% | -120% | n/a |
| Monopar Therapeutics MNPR | Biotechnology | $479M | -5% | +9% | n/a | n/a | n/a |
| Neurogene NGNE | Biotechnology | $479M | -9% | -14% | -100% | n/a | n/a |
| AngioDynamics ANGO | Medical Specialties | $476M | -4% | -4% | +8% | -6% | n/a |
| Aquestive Therapeutics AQST | Pharmaceuticals: Major | $475M | -7% | -9% | +13% | -114% | n/a |